These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 17612311)

  • 1. Managing difficult-to-treat asthma: Lessons from a center of excellence in allergy and asthma care.
    Smits W; Letz K
    J Med Pract Manage; 2007; 22(6):350-8. PubMed ID: 17612311
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anti-IgE in severe persistent allergic asthma.
    Fox H
    Respirology; 2007 Nov; 12 Suppl 3():S22-8; discussion S45-7. PubMed ID: 17956516
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Asthma 2008: targeting immunoglobulin E to achieve disease control.
    Prenner BM
    J Asthma; 2008 Aug; 45(6):429-36. PubMed ID: 18612893
    [TBL] [Abstract][Full Text] [Related]  

  • 4. IgE-blocking therapy for difficult-to-treat asthma: a brief review.
    Marshall GD; Sorkness CA
    Manag Care; 2004 Mar; 13(3):45-50. PubMed ID: 15074156
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Many asthma patients experience persistent symptoms despite appropriate clinical and guideline-based treatment with inhaled corticosteroids.
    Mogil J
    J Am Acad Nurse Pract; 2007 Sep; 19(9):459-70. PubMed ID: 17760570
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunoglobulin E-mediated airway inflammation is active in most patients with asthma.
    Hayden ML
    J Am Acad Nurse Pract; 2007 Sep; 19(9):439-49. PubMed ID: 17760568
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reduction of the total IgE level by omalizumab in children and adolescents.
    Steiss JO; Strohner P; Zimmer KP; Lindemann H
    J Asthma; 2008 Apr; 45(3):233-6. PubMed ID: 18415832
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effectiveness of omalizumab in patients with inadequately controlled severe persistent allergic asthma: an open-label study.
    Niven R; Chung KF; Panahloo Z; Blogg M; Ayre G
    Respir Med; 2008 Oct; 102(10):1371-8. PubMed ID: 18657960
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anti-immunoglobulin E therapy with omalizumab for asthma.
    Hendeles L; Sorkness CA
    Ann Pharmacother; 2007 Sep; 41(9):1397-410. PubMed ID: 17698897
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of omalizumab on the need for rescue systemic corticosteroid treatment in patients with moderate-to-severe persistent IgE-mediated allergic asthma: a pooled analysis.
    Busse WW; Massanari M; Kianifard F; Geba GP
    Curr Med Res Opin; 2007 Oct; 23(10):2379-86. PubMed ID: 17711616
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Omalizumab in the treatment of severe asthma: efficacy and current problems.
    Pelaia G; Renda T; Romeo P; Busceti MT; Maselli R
    Ther Adv Respir Dis; 2008 Dec; 2(6):409-21. PubMed ID: 19124386
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An evaluation of the cost-effectiveness of omalizumab for the treatment of severe allergic asthma.
    Sullivan SD; Turk F
    Allergy; 2008 Jun; 63(6):670-84. PubMed ID: 18445184
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunoglobulin E blockade in the treatment of asthma.
    Kuhn R
    Pharmacotherapy; 2007 Oct; 27(10):1412-24. PubMed ID: 17896896
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Asthma symptom re-emergence after omalizumab withdrawal correlates well with increasing IgE and decreasing pharmacokinetic concentrations.
    Slavin RG; Ferioli C; Tannenbaum SJ; Martin C; Blogg M; Lowe PJ
    J Allergy Clin Immunol; 2009 Jan; 123(1):107-113.e3. PubMed ID: 19130931
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Use of omalizumab in a severe asthma clinic.
    Gibson PG; Taramarcaz P; McDonald VM
    Respirology; 2007 Nov; 12 Suppl 3():S35-44; discussion S45-7. PubMed ID: 17956518
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Treatment of severe asthma with anti-immunoglobulin E (Omalizumab). A new possibility in pulmonary medicine].
    Nolte H; Harving H; Backer V
    Ugeskr Laeger; 2007 Dec; 169(50):4366-7. PubMed ID: 18211797
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Unmet need in inadequately controlled asthma.
    Beasley R
    Respirology; 2007 Nov; 12 Suppl 3():S18-21; discussion S45-7. PubMed ID: 17956515
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The appropriate omalizumab patient.
    Karpel J; Bukstein DA; LoNigro R
    Manag Care; 2007 May; 16(5):44-50, 56. PubMed ID: 17552338
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Asthma management pocket reference 2008.
    van Weel C; Bateman ED; Bousquet J; Reid J; Grouse L; Schermer T; Valovirta E; Zhong N
    Allergy; 2008 Aug; 63(8):997-1004. PubMed ID: 18691302
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Improving efficiencies in the GI practice of endoscopic ambulatory surgery center.
    Overholt BF
    J Clin Gastroenterol; 2007 Apr; 41(4):352-5. PubMed ID: 17413600
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.